glp 1 drugs and parkinson's disease Glucagon-like peptide-1 (GLP-1) receptor agonists neuroinflammation: Implications for neurodegenerative treatment Pipeline Parkinson's drugs could revolutionise
Description
FOR SEMAGLUTIDE SOURCE: MedlinePlus
The review will adhere to the methodology outlined in the Joanna Briggs Institute Reviewers Manual [2], and will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) [8]
doi: 10.1111/dom.13979 [DOI] [PMC free article] [PubMed] [Google Scholar] 31.Frias JP, Nauck MA, Van J, et al
Factors such as diet, physical activity, sleep quality, underlying medical conditions, other medications, and individual metabolism can all influence both side effects and overall results
Which Has More Nausea
